ExodusPoint Capital Management’s Hims & Hers Health HIMS Stock Holding History

ExodusPoint Capital Management’s Portfolio HIMS Stock Details HIMS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-90,810	Closed	-$2.2M	–	1691
2024 Q4	$2.2M	Buy	90,810 +52,708	+138%	+$1.31M	0.02%	684
2024 Q3	$702K	Sell	38,102 -9,262	-20%	-$166K	﹤0.01%	1082
2024 Q2	$956K	Buy	+47,364	New	+$788K	0.01%	1034
2023 Q4	–	Sell	-55,282	Closed	-$348K	–	1712
2023 Q3	$348K	Sell	55,282 -93,490	-63%	-$695K	﹤0.01%	1371
2023 Q2	$1.4M	Buy	+148,772	New	+$1.48M	0.01%	965
2022 Q3	–	Sell	-75,682	Closed	-$343K	–	2059
2022 Q2	$343K	Sell	75,682 -157,202	-68%	-$670K	﹤0.01%	1488
2022 Q1	$1.24M	Buy	232,884 +154,084	+196%	+$762K	0.02%	1026
2021 Q4	$516K	Buy	+78,800	New	+$570K	0.01%	1376
2021 Q3	–	Sell	-25,103	Closed	-$273K	–	2333
2021 Q2	$273K	Sell	25,103 -278,029	-92%	-$3.31M	﹤0.01%	1797
2021 Q1	$4.01M	Sell	303,132 -344,964	-53%	-$5.78M	0.06%	342
2020 Q4	$9.46M	Buy	+648,096	New	+$7.2M	0.09%	129

Other funds holding HIMS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

SIM

SRS Investment Management New York $9.47B AUM 60.12% 1-Year Est. Return

ExodusPoint Capital Management's HIMS Position: Q1 2025 in Review

ExodusPoint Capital Management sold out of Hims & Hers Health (HIMS) in Q1 2025, closing a stake of 90,810 shares — an estimated $2.2M sold.

ExodusPoint Capital Management first reported a position in HIMS in Q4 2020 and held it in 11 quarters. The position peaked at $9.46M in Q4 2020. 429 funds tracked by Wall St. Rank hold HIMS as of Q1 2025.

ExodusPoint Capital Management reported no remaining Hims & Hers Health position as of Q1 2025 after selling out during the quarter.
ExodusPoint Capital Management sold 90,810 Hims & Hers Health shares in Q1 2025, an estimated $2.2M.
ExodusPoint Capital Management first reported a position in Hims & Hers Health in Q4 2020 and held it in 11 quarters.
ExodusPoint Capital Management's Hims & Hers Health position peaked at $9.46M in Q4 2020.
429 funds tracked by Wall St. Rank held Hims & Hers Health as of Q1 2025.

Based on ExodusPoint Capital Management's 13F filing for Q1 2025, filed 14 May 2025.